BRCA2 and breast cancer: In humans, truncating mutations of exon 11 of BRCA2 are associated with ovarian and breast cancer predisposition [128,129,130] (Breast Cancer Information Core, http://research.nhgri.nih.gov/bic/ accessed on 18 April 2021).